Crystalline form B of risperidone

The asymmetric unit of the title compound {systematic name: 4‐(6‐fluoro‐1,2‐benzisoxazol‐3‐yl)‐1‐hydr­oxy‐1‐[2‐(2‐methyl‐4‐oxo‐3,4,6,7,8,9‐hexa­hydro‐2H‐pyrido[1,2‐a]pyrimidin‐3‐yl)­eth­yl]piperidine}, C23H27FN4O2, contains two independent risperidone mol­ecules. The piperidine and the tetra­hydro­p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta crystallographica. Section E, Structure reports online Structure reports online, 2006-08, Vol.62 (8), p.o3527-o3528
Hauptverfasser: Wang, Dan‐Hua, Zhou, Ming‐Hua, Hu, Xiu‐Rong
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The asymmetric unit of the title compound {systematic name: 4‐(6‐fluoro‐1,2‐benzisoxazol‐3‐yl)‐1‐hydr­oxy‐1‐[2‐(2‐methyl‐4‐oxo‐3,4,6,7,8,9‐hexa­hydro‐2H‐pyrido[1,2‐a]pyrimidin‐3‐yl)­eth­yl]piperidine}, C23H27FN4O2, contains two independent risperidone mol­ecules. The piperidine and the tetra­hydro­pyridine rings adopt chair and sofa conformations, respectively.
ISSN:1600-5368
1600-5368
DOI:10.1107/S1600536806027930